Optimizing Timing of CABG in Patients Presenting With ACS and Treated With Ticagrelor

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 260 participants.

Also called NCT02627521

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 260 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02627521
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02627521. Randomized; triple masking; primary purpose treatment. Start 2015-07 (registry gives no type); primary completion 2017-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Optimizing Timing of CABG in Patients Presenting With ACS and Treated With Ticagrelor
Acronym
CABG-TIME
Intervention (Procedure)
PRU guided CABG (coronary artery bypass grafting)
Intervention (Procedure)
CABG per standard of care
Intervention (Device)
VerifyNow assay
Intervention (Drug)
Ticagrelor
Lead sponsor
Unity Health Toronto (class: other)

Record details

Record id
cardio:ct-nct02627521
Content hash
7fe634aaee9f1c5193021861753e439da4aa475010e54d87a979d37701045e5e